#gcgenome — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gcgenome, aggregated by home.social.
-
South Korea’s IPO market sees Linksolution and GC Genome debut on KOSDAQ this week, while GFC Life Science and others set IPO prices through institutional bookbuilding.
#YonhapInfomax #IPO #KOSDAQ #Linksolution #GCGenome #Bookbuilding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66570 -
GC Genome’s IPO faces ongoing regulatory risks over internal transactions, as South Korea’s antitrust watchdog intensifies scrutiny of the biotech sector.
#YonhapInfomax #GCGenome #InternalTransactions #IPO #KoreaFairTradeCommission #RegulatoryRisk #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65340 -
GC Genome’s IPO highlights concerns over overlapping listings within GC Group, raising fears of shareholder value dilution and renewed scrutiny of the “Korea Discount.”
#YonhapInfomax #GCGenome #OverlappingListings #ShareholderValue #KoreaDiscount #GCGroupAffiliates #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65337 -
GC Genome's planned dual listing has sparked concerns over conflicts of interest between parent and subsidiary shareholders due to high intra-group transactions, with experts warning of potential negative impacts on share price and the Korea Discount.
#YonhapInfomax #GCGenome #DualListing #InternalTransactions #KoreaDiscount #ShareholderConflict #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65339 -
GC Genome set its IPO price at the top of its range after institutional demand reached a 547-to-1 bid ratio, raising 42 billion won and targeting KOSDAQ listing in June.
#YonhapInfomax #GCGenome #IPO #InstitutionalDemand #KOSDAQ #MarketCapitalization #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64932 -
South Korea’s IPO market sees Linksolution and GC Genome launch retail subscriptions this week, while Dow InSys and others begin institutional demand forecasting, with total offerings exceeding $70 million.
#YonhapInfomax #IPO #Linksolution #GCGenome #DowInSys #DemandForecasting #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64670 -
GC Genome aims to revolutionize early cancer detection with innovative liquid biopsy technology, targeting global leadership in clinical genomics analysis through upcoming IPO.
#YonhapInfomax #GCGenome #LiquidBiopsy #CancerDetection #IPO #ClinicalGenomics #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64550 -
GC Genome aims to revolutionize early cancer detection with innovative liquid biopsy technology, targeting global leadership in clinical genomics analysis through upcoming IPO.
#YonhapInfomax #GCGenome #LiquidBiopsy #CancerDetection #IPO #ClinicalGenomics #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64550 -
GC Genome aims to revolutionize early cancer detection with innovative liquid biopsy technology, targeting global leadership in clinical genomics analysis through upcoming IPO.
#YonhapInfomax #GCGenome #LiquidBiopsy #CancerDetection #IPO #ClinicalGenomics #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64550 -
GC Genome aims to revolutionize early cancer detection with innovative liquid biopsy technology, targeting global leadership in clinical genomics analysis through upcoming IPO.
#YonhapInfomax #GCGenome #LiquidBiopsy #CancerDetection #IPO #ClinicalGenomics #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64550 -
GC Genome aims to revolutionize early cancer detection with innovative liquid biopsy technology, targeting global leadership in clinical genomics analysis through upcoming IPO.
#YonhapInfomax #GCGenome #LiquidBiopsy #CancerDetection #IPO #ClinicalGenomics #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64550